Mole Removal in India & UAE — Surgical & Laser Excision from $150
Mole removal in India from $150. Surgical excision, shave biopsy & laser removal with histopathology by expert dermatologists. Same-day procedure. Book with GAF Healthcare.
Estimated cost: $150 – $600 · Average stay: Same day
A mole (melanocytic naevus) is a benign growth arising from melanocytes — the pigment-producing cells of the skin. Most people have between 10 and 40 moles; they can be flat or raised, flesh-coloured, brown, or black, and can appear anywhere on the body from birth (congenital naevi) or develop throughout life (acquired naevi). The vast majority of moles are entirely benign. However, some moles develop concerning features — asymmetry, irregular borders, colour variation, large diameter, or change over time (the ABCDEs of melanoma) — that require medical evaluation and excision to exclude melanoma.
Mole removal is performed for two distinct reasons: medical (diagnostic excision of a suspicious or atypical mole to exclude malignancy) and cosmetic (removal of a benign but aesthetically bothersome mole). In both cases, proper technique and histopathological assessment of the removed tissue are best practice.
India and the UAE have experienced dermatologists and dermatological surgeons who perform mole removal using the complete range of techniques — surgical excision, shave excision, punch biopsy, and laser removal — at costs far below equivalent private dermatology in the UK, USA, or Western Europe.
Types of Moles and Why Removal Is Needed
Congenital melanocytic naevi (CMN) present at birth or in the first few months of life. Small CMN (less than 1.5 cm) have a low lifetime malignancy risk. Medium (1.5–20 cm) and large (giant, over 20 cm) CMN carry a higher malignancy risk — particularly large CMN on the scalp or midline back, which may have a 2–5% lifetime risk of melanoma development. Large CMN may also cause significant self-consciousness and social difficulty, making elective staged removal a reasonable option when feasible.
Acquired naevi (common moles) develop after birth and increase in number through childhood and adulthood. Common acquired naevi are almost universally benign. Atypical (dysplastic) naevi are common moles that have developed irregular features on dermoscopy — they are not malignant but may represent a higher risk marker for melanoma development in individuals with multiple dysplastic naevi (dysplastic naevus syndrome).
Suspicious moles — those with ABCDE changes (Asymmetry, irregular Border, Colour variation with multiple shades, Diameter over 6mm, or any Evolution/change in size, shape, or colour) — require prompt dermatological assessment and excision with a safety margin to exclude melanoma. Dermoscopy (epiluminescence microscopy) dramatically improves the diagnostic accuracy of mole assessment, allowing trained dermatologists to distinguish benign from suspicious lesions and guide selective excision.
Seborrhoeic keratoses — warty, "stuck-on" lesions common in middle age and beyond — are frequently mistaken for moles but are completely benign epidermal proliferations with no malignancy risk. They can be removed cosmetically with cryotherapy, curettage, or laser.
Mole Removal Techniques
Surgical excision removes the mole and a margin of surrounding normal skin down to the subcutaneous fat, providing a complete specimen for histopathological analysis. It is the method of choice for any mole with suspicious features, large or flat moles, and congenital naevi. The wound is closed with fine sutures (non-absorbable for the skin, absorbable for deeper layers). It produces a linear scar, typically 2–3x the diameter of the removed mole, which matures to near-invisible at 12–18 months.
Shave excision (tangential excision) uses a blade or radio-frequency loop to shave the mole flush with or just below the skin surface. It is appropriate for raised, benign-appearing moles that are clearly above the skin surface. The wound heals by secondary intention (without sutures) over 2 weeks; the cosmetic result is typically excellent with a flat, pale mark. The specimen is sent for histopathology. The limitation of shave excision is that it does not remove the full depth of the mole — recurrence (re-pigmentation) is possible if melanocytes remain in the dermal base.
Punch biopsy removes a cylindrical core of the mole and dermis using a circular punch instrument (typically 3–4 mm diameter); the wound is closed with one or two sutures. This is used as a diagnostic biopsy for flat pigmented lesions that cannot be adequately assessed with shave technique.
Laser removal (Q-switched Nd:YAG or CO2 laser) is appropriate only for small, flat, clearly benign superficial pigmented lesions. It vaporises the melanocytes without providing a specimen for histopathology — which is why it should never be used for suspicious moles (where histopathological exclusion of malignancy is essential). Laser removal leaves minimal scarring and is ideal for cosmetic removal of small, flat benign naevi on the face.
Procedure Steps
- Dermoscopy assessment of the mole; clinical photography; suspicious features documented
- Referral for oncodermatology review if any concerning features identified
- Local anaesthetic injection (lidocaine with adrenaline) or topical cream (EMLA) for children
- Excision, shave, or laser removal performed according to clinical indication
- Wound closed (or dressed for shave/laser); antibiotic ointment applied
- Specimen labelled and sent to histopathology
- Histopathology result communicated within 48–72 hours; further management planned if needed
Cost Comparison Worldwide
Country — Range — Savings
--- — --- — ---
USA — $200 – $800 per mole — Save up to 75%
UK — £100 – £400 per mole — Save up to 65%
UAE — $200 – $600 per mole — Save up to 60%
India — $150 – $600 per mole — Best value
Single mole excision in the USA costs $200–$800 including the surgical fee and pathology. In India, the same procedure including dermoscopy assessment, excision, wound closure, and histopathology costs $150–$600 per mole. For patients requiring removal of multiple moles in a single session, India's per-mole cost reduces with volume and the session becomes significantly more economical. GAF Healthcare provides itemised per-mole quotes before commitment.
Recovery & Follow-up
Mole removal recovery is minimal. Surgical excision wounds heal within 10–14 days; sutures are removed at 7–10 days (or are absorbable and dissolve). Shave and laser wounds re-epithelialise within 7–14 days. The area should be kept clean, dry, and covered with antibiotic ointment and a small plaster for the first 5 days. Normal activities can be resumed immediately. Sun protection on the healing area for 12 months minimises scar pigmentation. Scar maturation takes 6–12 months; silicone gel application accelerates the process.
Recovery Tips
- Keep the wound covered with antibiotic ointment and a plaster for the first 5 days
- Keep the wound dry for 48 hours; then clean gently with saline or water daily
- Apply SPF 50+ sunscreen to the healed wound for 12 months — UV on healing scars causes permanent hyperpigmentation
- Begin silicone gel application from week 3–4 to minimise scar visibility
- Attend for suture removal at the scheduled time (7–10 days for facial sutures; 10–14 days for body)
- Have your remaining moles reviewed by a dermatologist annually — particularly if you have multiple moles, a family history of melanoma, or a history of significant sun exposure
Risks & Complications
Mole removal risks are minimal for properly selected and executed procedures. Scar formation is the most common outcome — all excisions produce a scar; the quality and visibility vary by technique, location, and individual healing. Infection occurs in approximately 1–2% of minor skin excisions. Recurrence (re-pigmentation) at the excision site can occur after shave excision if deep melanocytes remain — this is usually benign but requires dermoscopy review to exclude dysplasia. The most important risk is of an inadequate excision — failing to remove the full extent of a suspicious lesion — which is managed by ensuring all suspected lesions are excised with an appropriate safety margin (2 mm for clinically benign-appearing lesions, 2–5 mm for lesions suspicious for in-situ or invasive melanoma).
Why GAF Healthcare
GAF Healthcare connects patients with experienced dermatologists who perform comprehensive dermoscopy assessment before any mole removal — ensuring that no suspicious lesion is missed and that every excised specimen is sent for formal histopathological analysis. We can also arrange total-body dermoscopy photography (baseline mole mapping) for patients who wish to monitor all their moles systematically over time. All histopathology results are communicated to patients digitally within 72 hours and shared with their home country dermatologist on request.
Frequently Asked Questions
Should every mole be checked before removal?
Yes. Before any mole removal — including those being removed purely for cosmetic reasons — a trained dermatologist should assess the mole with dermoscopy to confirm it is benign. Removing a suspicious mole without dermoscopic assessment (by shaving, laser, or electrocautery) risks destroying a potentially malignant lesion without proper diagnosis and adequate margins. All excised moles should be sent for histopathological assessment.
Can I have multiple moles removed in one session?
Yes. Multiple moles can be removed in a single session under local anaesthetic, which is more efficient and cost-effective than separate appointments. In practice, 3–10 moles can comfortably be removed in one 60-90 minute session. Very large numbers of moles (more than 10–15) may be divided between two sessions for practicality.
What happens if my mole histopathology comes back abnormal?
The histopathology report will indicate the diagnosis: benign (no action needed), mildly dysplastic naevus (surveillance — annual dermatology review recommended; no further excision usually required), moderately or severely dysplastic naevus (re-excision with wider margins), or melanoma (urgent referral to an oncology multidisciplinary team for staging and further management). GAF Healthcare communicates all histopathology results to patients within 72 hours and arranges any required further procedures or oncology referrals.